AQB logo

AquaBounty Technologies, Inc. (AQB)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

AQB steht fuer AquaBounty Technologies, Inc., ein Consumer Defensive-Unternehmen mit einem Kurs von $0.94 (Marktkapitalisierung 4M). Die Aktie erzielt 53/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.

Zuletzt analysiert: 3. März 2026
53/100 KI-Bewertung MCap 4M Vol 49K

AquaBounty Technologies, Inc. (AQB) Konsumgueeter-Geschaeftsueberblick

AquaBounty Technologies pioneers sustainable aquaculture with its AquAdvantage Salmon, a bioengineered solution poised to revolutionize salmon production, addressing growing demand while minimizing environmental impact, positioning the company for significant growth in the evolving food technology landscape.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 3. März 2026

Investmentthese

Investing in AquaBounty Technologies presents a unique opportunity to capitalize on the growing demand for sustainable protein sources and advancements in aquaculture technology. The company's AquAdvantage Salmon offers a compelling value proposition by reducing the time to market and potentially lowering production costs compared to traditional salmon farming. With a gross margin of 100.0%, AquaBounty demonstrates the potential for high profitability as production scales. Key catalysts include expanding production capacity and securing additional regulatory approvals in key markets. The company's focus on genetic research and development positions it at the forefront of aquaculture innovation. As AquaBounty successfully scales its operations and gains wider market acceptance for its AquAdvantage Salmon, the stock offers significant upside potential. The high beta of 1.32 suggests higher volatility, which could translate to outsized gains if the company executes its growth strategy effectively.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Gross Margin of 100.0% indicates strong potential profitability as production scales.
  • Profit Margin of 12544.1% reflects the impact of fair value adjustments on biological assets.
  • Beta of 1.32 suggests higher volatility compared to the market.
  • Focus on AquAdvantage Salmon positions the company to capitalize on the growing demand for sustainable protein.
  • Genetic research and development activities drive innovation in the aquaculture industry.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Innovative AquAdvantage Salmon technology.
  • High gross margin potential.
  • First-mover advantage in the GE salmon market.
  • Strong focus on sustainability.

Schwaechen

  • Limited production capacity.
  • Dependence on regulatory approvals.
  • Small number of employees.
  • Public perception concerns regarding genetically engineered food.

Katalysatoren

  • Ongoing: Expansion of production capacity at existing facilities.
  • Ongoing: Pursuit of regulatory approvals in new markets.
  • Ongoing: Strategic partnerships with food retailers and distributors.
  • Upcoming: Potential for positive earnings surprises as production scales.

Risiken

  • Potential: Regulatory delays or denials in key markets.
  • Ongoing: Negative consumer perception of genetically engineered food.
  • Potential: Competition from traditional salmon farms.
  • Ongoing: Dependence on a single product (AquAdvantage Salmon).
  • Ongoing: Dilution risk due to the need for additional capital to fund expansion.

Wachstumschancen

  • Expansion of Production Capacity: AquaBounty can significantly increase its revenue by expanding its production facilities. Investing in larger, more efficient farms will allow the company to meet growing demand for AquAdvantage Salmon. The global salmon market is estimated to be worth billions of dollars, providing a substantial opportunity for AquaBounty to capture a larger market share. Timeline: Ongoing.
  • Securing Regulatory Approvals in New Markets: Obtaining regulatory approvals in key markets, such as Europe and Asia, will open up new avenues for growth. These markets represent a significant portion of global salmon consumption. Successful navigation of regulatory processes will be crucial for AquaBounty's international expansion. Timeline: Ongoing.
  • Strategic Partnerships and Distribution Agreements: Forming strategic partnerships with major food retailers and distributors will enhance AquaBounty's market reach and brand recognition. Collaborations with established players in the food industry will facilitate the distribution and sale of AquAdvantage Salmon. Timeline: Ongoing.
  • Development of New Genetically Engineered Products: AquaBounty can leverage its expertise in genetic engineering to develop new products for the aquaculture industry. This could include genetically enhanced versions of other commercially important fish species. Diversifying its product portfolio will reduce the company's reliance on a single product. Timeline: Ongoing.
  • Licensing of AquAdvantage Technology: Licensing its AquAdvantage technology to other aquaculture companies can generate a recurring revenue stream for AquaBounty. This would allow the company to capitalize on its intellectual property without directly investing in additional production facilities. Timeline: Ongoing.

Chancen

  • Expansion into new geographic markets.
  • Strategic partnerships with food retailers.
  • Development of new genetically engineered products.
  • Licensing of AquAdvantage technology.

Risiken

  • Competition from traditional salmon farms.
  • Regulatory hurdles and delays.
  • Negative consumer perception of GE food.
  • Potential for environmental concerns related to aquaculture.

Wettbewerbsvorteile

  • Proprietary AquAdvantage technology protected by patents.
  • First-mover advantage in the genetically engineered salmon market.
  • Specialized expertise in aquaculture and genetic engineering.
  • Regulatory approvals for AquAdvantage Salmon in key markets.

Ueber AQB

AquaBounty Technologies, Inc., established in 1991 and headquartered in Maynard, Massachusetts, is a biotechnology company dedicated to improving productivity in the commercial aquaculture industry. Originally named Aqua Bounty Farms, Inc., the company rebranded in 2004 to reflect its focus on technological advancements. AquaBounty's core business revolves around genetic, genomic, and fish health and nutrition research activities. The company's flagship product is AquAdvantage Salmon, a genetically engineered Atlantic salmon designed for human consumption. This innovative product grows to market size faster than conventional Atlantic salmon, potentially reducing the environmental footprint and increasing the efficiency of salmon farming. In addition to AquAdvantage Salmon, AquaBounty sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. AquaBounty aims to address the increasing global demand for seafood while promoting sustainable aquaculture practices through its bioengineered salmon and related technologies. With a small team of 4 employees, AquaBounty is focused on scaling production and distribution of its AquAdvantage Salmon.

Was das Unternehmen tut

  • Develops and markets AquAdvantage Salmon, a genetically engineered Atlantic salmon.
  • Conducts genetic, genomic, and fish health and nutrition research.
  • Sells conventional Atlantic salmon, salmon eggs, and fry.
  • Focuses on enhancing productivity in the commercial aquaculture industry.
  • Aims to provide a sustainable solution to meet the growing demand for seafood.
  • Utilizes biotechnology to improve the efficiency of salmon farming.

Geschaeftsmodell

  • Generates revenue through the sale of AquAdvantage Salmon.
  • Sells conventional Atlantic salmon, salmon eggs, and fry.
  • Focuses on research and development to improve aquaculture practices.
  • Aims to license its AquAdvantage technology to other aquaculture companies.

Branchenkontext

AquaBounty operates within the agricultural farm products industry, a segment of the broader consumer defensive sector. The industry is characterized by increasing demand for sustainable food production methods and innovative technologies to enhance efficiency. The competitive landscape includes traditional aquaculture farms and other biotechnology companies focused on improving crop and livestock yields. AquaBounty differentiates itself through its AquAdvantage Salmon, offering a faster growth cycle and potentially lower environmental impact. The global aquaculture market is projected to continue growing, driven by rising seafood consumption and the need for sustainable alternatives to wild-caught fish.

Wichtige Kunden

  • Food retailers and distributors.
  • Restaurants and foodservice providers.
  • Consumers seeking sustainable seafood options.
KI-Zuversicht: 75% Aktualisiert: 3. März 2026

Finanzdaten

Chart & Info

AquaBounty Technologies, Inc. (AQB) Aktienkurs: $0.94 (-0.02, -2.40%)

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer AQB.

Kursziele

Wall-Street-Kurszielanalyse fuer AQB.

MoonshotScore

53/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von AQB auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Haeufige Fragen zu AQB

What are the key factors to evaluate for AQB?

AquaBounty Technologies, Inc. (AQB) currently holds an AI score of 53/100, indicating moderate score. Key strength: Innovative AquAdvantage Salmon technology.. Primary risk to monitor: Potential: Regulatory delays or denials in key markets.. This is not financial advice.

How frequently does AQB data refresh on this page?

AQB prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven AQB's recent stock price performance?

Recent price movement in AquaBounty Technologies, Inc. (AQB) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Innovative AquAdvantage Salmon technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider AQB overvalued or undervalued right now?

Determining whether AquaBounty Technologies, Inc. (AQB) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying AQB?

Before investing in AquaBounty Technologies, Inc. (AQB), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding AQB to a portfolio?

Potential reasons to consider AquaBounty Technologies, Inc. (AQB) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Innovative AquAdvantage Salmon technology.. Additionally: High gross margin potential.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of AQB?

Yes, most major brokerages offer fractional shares of AquaBounty Technologies, Inc. (AQB) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track AQB's earnings and financial reports?

AquaBounty Technologies, Inc. (AQB) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for AQB earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on available data and may be subject to change.
  • Investment decisions should be based on individual risk tolerance and financial circumstances.
Datenquellen

Popular Stocks